Gilead Sciences | Costo Del Venduto



Cost Of Sales Cambiamento Data
AbbVie USD 4B 394M 2025-03
Agios Pharmaceuticals USD 1.08M 175K 2025-03
ALKERMES USD 49.2M 12.92M 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amgen USD 2.6B 507M 2025-03
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Incyte USD 67.8M 14.58M 2025-03
J&J USD 7.3B 189M 2025-03
Merck USD 2.76B 944M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
PTC Therapeutics USD 12.86M 3.42M 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Sanofi EUR 2.89B 618M 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
United Therapeutics USD 277.5M 201.6M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Gilead Sciences Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.